Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Colorectal Neoplasms 2 Breast Diseases 2 Thrombocythemia, Essential 1 Polycythemia Vera 1 Lymphedema 1 Liver Neoplasms 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Eunuchism 1 Adenoma 1

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 Hepatectomy 13 lenvatinib 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5 apatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Drug Evaluation × Clear all

NCT05913141 2023-06-22

PDO/PDO-TIL/PDOTS for Drug Screen

Shanghai Zhongshan Hospital

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡